Clinical Trial Update: Evaluating Collagen Cross-Linking (CCL) Treatment in Norway [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial in Norway is evaluating collagen cross-linking for keratoconus in Phase 2 and Phase 3. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Collagen Cross-Linking

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Keratoconus | Phase 2, Phase 3 | Status: UNKNOWN